Publication: Therapeutic drug monitoring of lopinavir in human immunodeficiency virus-infected children receiving adult tablets
1
item.page.dc.date.issued
2010-01-01
item.page.dc.type
item.page.dc.identifier.issn
15320987
08913668
08913668
item.page.dc.identifier.doi
item.page.dc.identifier.other
2-s2.0-74049099818
item.page.dc.rights
Mahidol University
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Pediatric Infectious Disease Journal. Vol.29, No.1 (2010), 79-82
punsarn.item.page.citation
Thanyawee Puthanakit, Kulkanya Chokephaibulkit, Piyarat Suntarattiwong, Meena Gorowara, Nirun Vanprapar, Pimsiri Leawsrisuk, Tulathip Suwanlerk, Pitch Boonrak, Kiat Ruxrungtham Therapeutic drug monitoring of lopinavir in human immunodeficiency virus-infected children receiving adult tablets. Pediatric Infectious Disease Journal. Vol.29, No.1 (2010), 79-82. doi:10.1097/INF.0b013e3181b21040 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/29882
Research Projects
Organizational Units
Authors
Journal Issue
relationships.isThesisOf
item.page.dc.title
Therapeutic drug monitoring of lopinavir in human immunodeficiency virus-infected children receiving adult tablets
item.page.dc.contributor.author
item.page.dc.description.abstract
Because of the lack of a lopinavir/ritonavir (LPV/r) pediatric formulation, 54 HIV-infected children were given generic LPV/r adult tablets. Of 54 children, 21 took cut pills to get the appropriate dose. The median (interquartile range) LPV trough serum concentration (Ctrough) was 6.7 (5.0-9.9) mg/L. All the children had Ctrough >1.0 mg/L and 96% had values >4.0 mg/L. LPV/r adult tablets can be used in children when it is necessary. © 2009 by Lippincott Williams & Wilkins.
